Epileptic fits and epilepsy in the elderly: General reflections, specific issues and therapeutic implications

Clinical Neurology and Neurosurgery

Volumn 109, Issue 9, 2007, Pages 727-743

  Sheorajpanday, Rishi V A ^a,b   De Deyn, Peter P ^a,b  

^a ZNA Middelheim ^*  (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Anti epileptic drugs; Carbamazepine; Elderly; Epilepsy; Epileptic fit; Gabapentin; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Pregabalin; Seizure; Status epilepticus; Topiramate; Valproic acid

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOMIPRAMINE; DOPAMINE UPTAKE INHIBITOR; ETIRACETAM; FLUVOXAMINE; FOLIC ACID; GABAPENTIN; IMIPRAMINE; LAMOTRIGINE; NORADRENALIN UPTAKE INHIBITOR; OXCARBAZEPINE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; VITAMIN D; WARFARIN;

AGED; AGGRESSION; AGITATION; ANORGASMIA; ASTHENIA; ATAXIA; BLOOD DYSCRASIA; BLURRED VISION; BONE MARROW SUPPRESSION; BULLOUS SKIN DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; COARSE FACIES; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; DEPRESSION; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG CHOICE; DRUG CROSS REACTIVITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DUPUYTREN CONTRACTURE; ELDERLY CARE; ELECTROENCEPHALOGRAM; EPILEPSY; FALL RISK; FATIGUE; FOLIC ACID DEFICIENCY; GAIT DISORDER; GINGIVA HYPERTROPHY; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEPATITIS; HUMAN; HYPONATREMIA; HYPOTENSION; IMPOTENCE; INSOMNIA; IRRITABILITY; KIDNEY FAILURE; LIBIDO DISORDER; LIVER FUNCTION TEST; MEMORY DISORDER; MOOD DISORDER; MYOCLONUS; NAUSEA; NEPHROLITHIASIS; NEUROPATHY; NYSTAGMUS; OSTEOMALACIA; PARESTHESIA; PHYSICAL EXAMINATION; PSYCHOSIS; PURPLE GLOVE; QT PROLONGATION; RASH; REVIEW; RHINITIS; RISK BENEFIT ANALYSIS; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; SPEECH DISORDER; STEVENS JOHNSON SYNDROME; SYSTEMATIC REVIEW; TREMOR; VITAMIN D DEFICIENCY; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

AGE FACTORS; AGED; ANTICONVULSANTS; ELECTRIC STIMULATION THERAPY; EPILEPSY; HUMANS; NEUROSURGICAL PROCEDURES; RISK FACTORS;

EID: 34548656630     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2007.07.002     Document Type: Review

References (167)

1. Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47 (2006) 1094-1120
2. Scottish Intercollegiate Guidelines Network, Diagnosis and Management of Epilepsy in Adults. A national clinical guideline, http://www.sign.ac.uk/pdf/sign70.pdf, 2003.
3. National Institute for Clinical Excellence, The epilepsies: diagnosis and management of the epilepsies in adults in primary and secondary care, http://www.nice.org.uk/pdf/CG020NICEguideline.pdf, 2004.
4. Brodie M.J., and Kwan P. Epilepsy in elderly people. BMJ 331 (2005) 1317-1322
5. Cloyd J., Hauser W., Towne A., Ramsay R., Mattson R., Gilliam F., et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 68 Suppl. 1 (2006) S39-S48
6. Forsgren L., Bucht G., Eriksson S., and Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults: a prospective population-based study. Epilepsia 37 (1996) 224-229
7. Hauser W.A., Annegers J.F., and Kurland L.T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 34 (1993) 453-468
8. Ruggles K.H., Haessly S.M., and Berg R.L. Prospective study of seizures in the elderly in the Marshfield Epidemiologic Study Area (MESA). Epilepsia 42 (2001) 1594-1599
9. Waterhouse E.J., and DeLorenzo R.J. Status epilepticus in older patients: epidemiology and treatment options. Drugs Aging 18 (2001) 133-142
10. Knake S., Rosenow F., Vescovi M., Oertel W.H., Mueller H.H., Wirbatz A., et al. Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42 (2001) 714-718
11. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., and Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 58 (2002) 1070-1076
12. Vignatelli L., Tonon C., and D'Alessandro R. Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy. Epilepsia 44 (2003) 964-968
13. Knake S., Rochon J., Fleischer S., Katsarou N., Back T., Vescovi M., et al. Status epilepticus after stroke is associated with increased long-term case fatality. Epilepsia 47 (2006) 2020-2026
14. Franson K.L., Hay D.P., Neppe V., Dahdal W.Y., Mirza W.U., Grossberg G.T., et al. Drug-induced seizures in the elderly. Causative agents and optimal management. Drugs Aging 7 (1995) 38-48
15. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol Scand Suppl 180 (2003) 33-36
16. Burn J., Dennis M., Bamford J., Sandercock P., Wade D., and Warlow C. Epileptic seizures after a first stroke: the Oxfordshire community stroke project. BMJ 315 (1997) 1582-1587
17. Arboix A., Garcia-Eroles L., Massons J.B., Oliveres M., and Comes E. Predictive factors of early seizures after acute cerebrovascular disease. Stroke 28 (1997) 1590-1594
18. Asconape J.J., and Penry J.K. Poststroke seizures in the elderly. Clin Geriatr Med 7 (1991) 483-492
19. Rumbach L., Sablot D., Berger E., Tatu L., Vuillier F., and Moulin T. Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 54 (2000) 350-354
20. Bladin C.F., Alexandrov A.V., Bellavance A., Bornstein N., Chambers B., Cote R., et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 57 (2000) 1617-1622
21. Lossius M.I., Ronning O.M., Slapo G.D., Mowinckel P., and Gjerstad L. Poststroke epilepsy: occurrence and predictors-a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 46 (2005) 1246-1251
22. Benbir G., Ince B., and Bozluolcay M. The epidemiology of post-stroke epilepsy according to stroke subtypes. Acta Neurol Scand 114 (2006) 8-12
23. Cheung C.M., Tsoi T.H., Au-Yeung M., and Tang A.S. Epileptic seizure after stroke in Chinese patients. J Neurol 250 (2003) 839-843
24. DeReuck J., Goethals M., Vonck K., and Van M.G. Clinical predictors of late-onset seizures and epilepsy in patients with cerebrovascular disease. Eur Neurol 54 (2005) 68-72
25. Berges S., Moulin T., Berger E., Tatu L., Sablot D., Challier B., et al. Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 43 (2000) 3-8
26. Masuhr F., Busch M., Amberger N., Ortwein H., Weih M., Neumann K., et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 13 (2006) 852-856
27. Claassen J., Peery S., Kreiter K.T., Hirsch L.J., Du E.Y., Connolly E.S., et al. Predictors and clinical impact of epilepsy after subarachnoid hemorrhage. Neurology 60 (2003) 208-214
28. Hasan D., Schonck R.S., Avezaat C.J., Tanghe H.L., van G.J., and van der Lugt P.J. Epileptic seizures after subarachnoid hemorrhage. Ann Neurol 33 (1993) 286-291
29. Hoh B.L., Chapman P.H., Loeffler J.S., Carter B.S., and Ogilvy C.S. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery 51 (2002) 303-309
30. Hofmeister C., Stapf C., Hartmann A., Sciacca R.R., Mansmann U., terBrugge K., et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 31 (2000) 1307-1310
31. DeReuck J., Goethals M., Claeys I., Van M.G., and De C.M. EEG findings after a cerebral territorial infarct in patients who develop early- and late-onset seizures. Eur Neurol 55 (2006) 209-213
32. Velioglu S.K., Ozmenoglu M., Boz C., and Alioglu Z. Status epilepticus after stroke. Stroke 32 (2001) 1169-1172
33. Afsar N., Kaya D., Aktan S., and Sykut-Bingol C. Stroke and status epilepticus: stroke type, type of status epilepticus, and prognosis. Seizure 12 (2003) 23-27
34. Hesdorffer D.C., Hauser W.A., Annegers J.F., Kokmen E., and Rocca W.A. Dementia and adult-onset unprovoked seizures. Neurology 46 (1996) 727-730
35. Mendez M.F., Catanzaro P., Doss R.C., ARguello R., and Frey W.H. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 7 (1994) 230-233
36. Amatniek J.C., Hauser W.A., Castillo-Castaneda C., Jacobs D.M., Marder K., Bell K., et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47 (2006) 867-872
37. Glantz M.J., Cole B.F., Forsyth P.A., Recht L.D., Wen P.Y., Chamberlain M.C., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000) 1886-1893
38. Wen P.Y., Schiff D., Kesari S., Drappatz J., Gigas D.C., and Doherty L. Medical management of patients with brain tumors. J Neurooncol 80 (2006) 313-332
39. Liigant A., Haldre S., Oun A., Linnamagi U., Saar A., Asser T., et al. Seizure disorders in patients with brain tumors. Eur Neurol 45 (2001) 46-51
40. Lynam L.M., Lyons M.K., Drazkowski J.F., Sirven J.I., Noe K.H., Zimmerman R.H., and Wilkens J.A. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 109 7 (2007) 634-638
41. Thompson D., Takeshita J., Thompson T., and Mulligan M. Selecting antiepileptic drugs for symptomatic patients with brain tumors. J Support Oncol 4 (2006) 411-416
42. Oberndorfer S., Schmal T., Lahrmann H., Urbanits S., Lindner K., and Grisold W. [The frequency of seizures in patients with primary brain tumors or cerebral metastases. An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology, Kaiser Franz Josef Hospital, Vienna]. Wien Klin Wochenschr 114 (2002) 911-916
43. Hildebrand J., Lecaille C., Perennes J., and Delattre J.Y. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65 (2005) 212-215
44. Luhdorf K., Jensen L.K., and Plesner A.M. Etiology of seizures in the elderly. Epilepsia 27 (1986) 458-463
45. Ozbek N., Cakir S., Gursel B., and Meydan D. Prognostic significance of seizure in patients with glioblastoma multiforme. Neurol India 52 (2004) 76-78
46. Maschio M., Dinapoli L., Zarabia A., and Jandolo B. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct Neurol 21 (2006) 15-19
47. Riva M., Salmaggi A., Marchioni E., Silvani A., Tomei G., Lorusso L., et al. Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group. Neurol Sci 27 (2006) 345-351
48. Sung C.Y., and Chu N.S. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurol Scand 80 (1989) 51-56
49. Cavaliere R., Farace E., and Schiff D. Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol 63 (2006) 1746-1749
50. Espay A.J., Kumar V., and Sarpel G. Anti-Hu-associated paraneoplastic limbic encephalitis presenting as rapidly progressive non-convulsive status epilepticus. J Neurol Sci 246 (2006) 149-152
51. Shavit Y.B., Graus F., Probst A., Rene R., and Steck A.J. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol 45 (1999) 255-258
52. Jacobs D.A., Fung K.M., Cook N.M., Schalepfer W.W., Goldberg H.I., and Stecker M.M. Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome. J Neurol Sci 213 (2003) 77-82
53. Fadul C.E., Stommel E.W., Dragnev K.H., Eskey C.J., and Dalmau J.O. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy. J Neurooncol 72 (2005) 195-198
54. Agrawal A., Timothy J., Pandit L., and Manju M. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg 108 (2006) 433-439
55. Annegers J.F., and Coan S.P. The risks of epilepsy after traumatic brain injury. Seizure 9 (2000) 453-457
56. Sander J.W., and Perucca E. Epilepsy and comorbidity: infections and antimicrobials usage in relation to epilepsy management. Acta Neurol Scand Suppl 180 (2003) 16-22
57. Wadia R.S., Makhale C.N., Kelkar A.V., and Grant K.B. Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography. J Neurol Neurosurg Psychiatry 50 (1987) 1298-1301
58. Oksi J., Kalimo H., Marttila R.J., Marjamaki M., Sonninen P., Nikoskelainen J., et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. Brain 119 Pt 6 (1996) 2143-2154
59. Kalita J., and Misra U.K. EEG changes in tuberculous meningitis: a clinicoradiological correlation. Electroencephalogr Clin Neurophysiol 107 (1998) 39-43
60. Timmermans M., and Carr J. Neurosyphilis in the modern era. J Neurol Neurosurg Psychiatry 75 (2004) 1727-1730
61. Wang K.W., Chang W.N., Chang H.W., Chuang Y.C., Tsai N.W., Wang H.C., et al. The significance of seizures and other predictive factors during the acute illness for the long-term outcome after bacterial meningitis. Seizure 14 (2005) 586-592
62. Berlit P. The prognosis and long-term course of viral encephalitis. J Neuroimmunol 20 (1988) 117-125
63. Chadha D.S., Handa A., Sharma S.K., Varadarajulu P., and Singh A.P. Seizures in patients with human immunodeficiency virus infection. J Assoc Physicians India 48 (2000) 573-576
64. Modi G., Modi M., Martinus I., and Vangu M. New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis-a clinical, radiological and SPECT scan study. J Neurol Sci 202 (2002) 29-34
65. Mekan S.F., Wasay M., Khelaeni B., Saeed Z., Hassan A., and Sheerani M. Herpes simplex encephalitis: analysis of 68 cases from a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 55 (2005) 146-148
66. Yazar S., Arman F., Yalcin S., Demirtas F., Yaman O., and Sahin I. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seizure 12 (2003) 107-109
67. Kumar G.R., Kumar S.M., and Misra S. Single-enhancing CT lesions in Indian patients with seizures: a review. Epilepsy Res 38 (2000) 91-104
68. Ngoungou E.B., Koko J., Druet-Cabanac M., ssengone-Zeh-Nguema Y., Launay M.N., Engohang E., et al. Cerebral malaria and sequelar epilepsy: first matched case-control study in Gabon. Epilepsia 47 (2006) 2147-2153
69. Rathlev N.K., Ulrich A.S., Delanty N., and D'Onofrio G. Alcohol-related seizures. J Emerg Med 31 (2006) 157-163
70. Castilla-Guerra L., del C.F.-M., Lopez-Chozas J.M., and Fernandez-Bolanos R. Electrolytes disturbances and seizures. Epilepsia 47 (2006) 1990-1998
71. Brouns R., and De Deyn P.P. Neurological complications in renal failure: a review. Clin Neurol Neurosurg 107 (2004) 1-16
72. Bhatia V., Singh R., and Acharya S.K. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut 55 (2006) 98-104
73. Manni R., Terzaghi M., Arbasino C., Sartori I., Galimberti C.A., and Tartara A. Obstructive sleep apnea in a clinical series of adult epilepsy patients: frequency and features of the comorbidity. Epilepsia 44 (2003) 836-840
74. Hollinger P., Khatami R., Gugger M., Hess C.W., and Bassetti C.L. Epilepsy and obstructive sleep apnea. Eur Neurol 55 (2006) 74-79
75. Malow B.A., Levy K., Maturen K., and Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 55 (2000) 1002-1007
76. Sheth R.D., Drazkowski J.F., Sirven J.I., Gidal B.E., and Hermann B.P. Protracted ictal confusion in elderly patients. Arch Neurol 63 (2006) 529-532
77. Ramsay R.E., Rowan A.J., and Pryor F.M. Special considerations in treating the elderly patient with epilepsy. Neurology 62 (2004) S24-S29
78. Rasmussen H.H., Sorensen H.T., Moller-Petersen J., Mortensen F.V., and Nielsen B. Bacterial meningitis in elderly patients: clinical picture and course. Age Ageing 21 (1992) 216-220
79. van de Beek D., de Gans J., Spanjaard L., Weisfelt M., Reitsma J.B., and Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351 (2004) 1849-1859
80. van der Wee N., Rinkel G.J., Hasan D., and van Gijn J. Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?. J Neurol Neurosurg Psychiatry 58 (1995) 357-359
81. Appenzeller S., Zeller C.B., nnichino-Bizzachi J.M., Costallat L.T., us-Silva L., Voetsch B., et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg 107 (2005) 371-378
82. Kubicki S., Scheuler W., and Wittenbecher H. Short-term sleep EEG recordings after partial sleep deprivation as a routine procedure in order to uncover epileptic phenomena: an evaluation of 719 EEG recordings. Epilepsy Res Suppl 2 (1991) 217-230
83. King M.A., Newton M.R., Jackson G.D., Fitt G.J., Mitchell L.A., Silvapulle M.J., et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 352 (1998) 1007-1011
84. LaRoche S.M., and Helmers S.L. Epilepsy in the elderly. Neurologist 9 (2003) 241-249
85. Van Cott A.C. Epilepsy and EEG in the elderly. Epilepsia 43 Suppl. 3 (2002) 94-102
86. McBride A.E., Shih T.T., and Hirsch L.J. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia 43 (2002) 165-169
87. Abubakr A., and Wambacq I. Seizures in the elderly: Video/EEG monitoring analysis. Epilepsy Behav 7 (2005) 447-450
88. Cleary P., Shorvon S., and Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 363 (2004) 1184-1186
89. Berg A.T., and Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 41 (1991) 965-972
90. Hauser W.A., Rich S.S., Lee J.R., Annegers J.F., and Anderson V.E. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 338 (1998) 429-434
91. Marson A., Jacoby A., Johnson A., Kim L., Gamble C., and Chadwick D. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365 (2005) 2007-2013
92. Annegers J.F., Hauser W.A., and Elveback L.R. Remission of seizures and relapse in patients with epilepsy. Epilepsia 20 (1979) 729-737
93. Cockerell O.C., Johnson A.L., Sander J.W., and Shorvon S.D. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 38 (1997) 31-46
94. Griffith H.R., Martin R.C., Bambara J.K., Marson D.C., and Faught E. Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment. Epilepsy Behav 8 (2006) 161-168
95. Smith D.B., Mattson R.H., Cramer J.A., Collins J.F., Novelly R.A., and Craft B. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 28 Suppl. 3 (1987) S50-S58
96. Prevey M.L., Delaney R.C., Cramer J.A., Cattanach L., Collins J.F., and Mattson R.H. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 53 (1996) 1008-1016
97. Bootsma H.P., Aldenkamp A.P., Diepman L., Hulsman J., Lambrechts D., Leenen L., et al. The effect of antiepileptic drugs on cognition: patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice. Epilepsia 47 Suppl. 2 (2006) 24-27
98. Blum D., Meador K., Biton V., Fakhoury T., Shneker B., Chung S., et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 67 (2006) 400-406
99. Groselj J., Guerrini R., Van O.J., Lahaye M., Schreiner A., and Schwalen S. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Scand 112 (2005) 144-150
100. Smith D., Baker G., Davies G., Dewey M., and Chadwick D.W. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 34 (1993) 312-322
101. Brodie M.J., Overstall P.W., and Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 37 (1999) 81-87
102. Aikia M., Kalviainen R., Sivenius J., Halonen T., and Riekkinen P.J. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 11 (1992) 199-203
103. Curran H.V., and Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 44 (1993) 529-533
104. Leach J.P., Girvan J., Paul A., and Brodie M.J. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 62 (1997) 372-376
105. Martin R., Meador K., Turrentine L., Faught E., Sinclair K., Kuzniecky R., et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 42 (2001) 764-771
106. Salinsky M.C., Binder L.M., Oken B.S., Storzbach D., Aron C.R., and Dodrill C.B. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 43 (2002) 482-490
107. Brodie M.J., Chadwick D.W., Anhut H., Otte A., Messmer S.L., Maton S., et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 43 (2002) 993-1000
108. Micuda S., Mundlova L., Anzenbacherova E., Anzenbacher P., Chladek J., Fuksa L., et al. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. Eur J Clin Pharmacol 60 (2004) 583-589
109. Lancman M. Psychosis and peri-ictal confusional states. Neurology 53 (1999) S33-S38
110. Gaitatzis A., Carroll K., Majeed A., and Sander W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 45 (2004) 1613-1622
111. Alldredge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 53 (1999) S68-S75
112. Acri A.A., and Henretig F.M. Effects of risperidone in overdose. Am J Emerg Med 16 (1998) 498-501
113. Calabrese J.R., Rapport D.J., Shelton M.D., Kujawa M., and Kimmel S.E. Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology 38 (1998) 185-191
114. Letterman L., and Markowitz J.S. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy 19 (1999) 565-572
115. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 50 (1998) 245-251
116. Ketter T.A., Wang P.W., Becker O.V., Nowakowska C., and Yang Y.S. The diverse roles of anticonvulsants in bipolar disorders. Ann Clin Psychiatry 15 (2003) 95-108
117. Kanner A.M., and Nieto J.C. Depressive disorders in epilepsy. Neurology 53 (1999) S26-S32
118. Hirsch E., Schmitz B., and Carreno M. Epilepsy, antiepileptic drugs (AEDs) and cognition. Acta Neurol Scand Suppl 180 (2003) 23-32
119. Perucca E., Berlowitz D., Birnbaum A., Cloyd J.C., Garrard J., Hanlon J.T., et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 68 Suppl. 1 (2006) S49-S63
120. Mattson R.H., and Cramer J.A. Epilepsy, sex hormones, and antiepileptic drugs. Epilepsia 26 Suppl. 1 (1985) S40-S51
121. Leris A.C., Stephens J., Hines J.E., and McNicholas T.A. Carbamazepine-related ejaculatory failure. Br J Urol 79 (1997) 485
122. Labbate L.A., and Rubey R.N. Gabapentin-induced ejaculatory failure and anorgasmia. Am J Psychiatry 156 (1999) 972
123. Brannon G.E., and Rolland P.D. Anorgasmia in a patient with bipolar disorder type 1 treated with gabapentin. J Clin Psychopharmacol 20 (2000) 379-381
124. Husain A.M., Carwile S.T., Miller P.P., and Radtke R.A. Improved sexual function in three men taking lamotrigine for epilepsy. South Med J 93 (2000) 335-336
125. Gilad R., Lampl Y., Eshel Y., and Sadeh M. Tonic-clonic seizures in patients taking sildenafil. BMJ 325 (2002) 869
126. Striano P., Zara F., Minetti C., and Striano S. Epileptic seizures can follow high doses of oral vardenafil. BMJ 333 (2006) 785
127. Stephen L.J., McLellan A.R., Harrison J.H., Shapiro D., Dominiczak M.H., Sills G.J., et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 8 (1999) 339-342
128. Andress D.L., Ozuna J., Tirschwell D., Grande L., Johnson M., Jacobson A.F., et al. Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 59 (2002) 781-786
129. Vestergaard P., Tigaran S., Rejnmark L., Tigaran C., Dam M., and Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand 99 (1999) 269-275
130. Ensrud K.E., Walczak T.S., Blackwell T., Ensrud E.R., Bowman P.J., and Stone K.L. Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62 (2004) 2051-2057
131. Mintzer S., Boppana P., Toguri J., and DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 47 (2006) 510-515
132. Goulden K.J., Dooley J.M., Camfield P.R., and Fraser A.D. Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 37 (1987) 1392-1394
133. Sandson N.B., Marcucci C., Bourke D.L., and Smith-Lamacchia R. An interaction between aspirin and valproate: the relevance of plasma protein displacement drug-drug interactions. Am J Psychiatry 163 (2006) 1891-1896
134. Pylvanen V., Pakarinen A., Knip M., and Isojarvi J. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy. Epilepsy Behav 8 (2006) 643-648
135. Wilding J., Van G.L., Rissanen A., Vercruysse F., and Fitchet M. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 28 (2004) 1399-1410
136. Treiman D.M., Meyers P.D., Walton N.Y., Collins J.F., Colling C., Rowan A.J., et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339 (1998) 792-798
137. Treiman D.M., and Walker M.C. Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res 68 Suppl. 1 (2006) S77-S82
138. Misra U.K., Kalita J., and Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology 67 (2006) 340-342
139. Peters C.N., and Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus-experience in 102 adult patients. Seizure 14 (2005) 164-169
140. Limdi N.A., Shimpi A.V., Faught E., Gomez C.R., and Burneo J.G. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 64 (2005) 353-355
141. Olsen K.B., Tauboll E., and Gjerstad L. Valproate is an effective, well-tolerated drug for treatment of status epilepticus/serial attacks in adults. Acta Neurol Scand Suppl 187 (2007) 51-54
142. Vecht C.J., and van Breemen M. Optimizing therapy of seizures in patients with brain tumors. Neurology 67 (2006) S10-S13
143. Sirven J.I., Wingerchuk D.M., Drazkowski J.F., Lyons M.K., and Zimmerman R.S. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79 (2004) 1489-1494
144. Newton H.B., Goldlust S.A., and Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 78 (2006) 99-102
145. Gidal B.E. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res 68 Suppl. 1 (2006) S65-S69
146. Neels H.M., Sierens A.C., Naelaerts K., Scharpe S.L., Hatfield G.M., and Lambert W.E. Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42 (2004) 1228-1255
147. Gidal B., and Anderson G. Epilepsy in the elderly: special pharmacotherapeutic considerations. Consul Pharm 13 (1998). http://www.ascp.com/publications/tcp/1998/jan/review1.shtml
148. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1016-1026
149. Pauletto G., and Bergonzi P. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice. Seizure 15 (2006) 150-155
150. Marson A.G., Al-Kharusi A.M., Alwaidh M., Appleton R., Baker G.A., Chadwick D.W., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1000-1015
151. Mauri Llerda J.A., Tejero C., Mercade J.M., Padro L.L., and Salas P.J. Lamotrigine and epilepsy in the elderly: observational study of low-dose monotherapy. Int J Clin Pract 59 (2005) 651-654
152. Fife T.D., Blum D., and Fisher R.S. Measuring the effects of antiepileptic medications on balance in older people. Epilepsy Res 70 (2006) 103-109
153. Gillham R., Bryant-Comstock L., and Kane K. Validation of the side effect and life satisfaction (SEALS) inventory. Seizure 9 (2000) 458-463
154. varez-Sabin J., Montaner J., Padro L., Molina C.A., Rovira R., Codina A., et al. Gabapentin in late-onset poststroke seizures. Neurology 59 (2002) 1991-1993
155. Gidal B.E., Baltes E., Otoul C., and Perucca E. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Res 64 (2005) 1-11
156. Ferrendelli J.A., French J., Leppik I., Morrell M.J., Herbeuval A., Han J., et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav 4 (2003) 702-709
157. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., et al. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46 (2005) 1407-1413
158. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45 Suppl. 6 (2004) 13-18
159. Brodie M.J. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 45 Suppl. 6 (2004) 19-27
160. Mohanraj R., and Brodie M.J. Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol 13 (2006) 277-282
161. Beghi E., and Tonini C. Surgery for epilepsy: assessing evidence from observational studies. Epilepsy Res 70 (2006) 97-102
162. Grivas A., Schramm J., Kral T., von L.M., Helmstaedter C., Elger C.E., et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia 47 (2006) 1364-1372
163. Gallo B.V. Epilepsy, surgery, and the elderly. Epilepsy Res 68 Suppl. 1 (2006) S83-S86
164. Boon P., Vonck K., De R.J., and Caemaert J. Vagus nerve stimulation for refractory epilepsy. Seizure 11 Suppl. A (2002) 448-455
165. Labar D. Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 13 (2004) 392-398
166. Spanaki M.V., Allen L.S., Mueller W.M., and Morris III G.L. Vagus nerve stimulation therapy: 5-year or greater outcome at a university-based epilepsy center. Seizure 13 (2004) 587-590
167. Hawkins N., Epstein D., Drummond M., Wilby J., Kainth A., Chadwick D., et al. Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making 25 (2005) 493-510